請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/93938
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 劉啟群 | zh_TW |
dc.contributor.advisor | Chi-Chun Liu | en |
dc.contributor.author | 蘇冠宇 | zh_TW |
dc.contributor.author | Kuan-Yu Su | en |
dc.date.accessioned | 2024-08-09T16:33:02Z | - |
dc.date.available | 2024-08-10 | - |
dc.date.copyright | 2024-08-09 | - |
dc.date.issued | 2024 | - |
dc.date.submitted | 2024-07-29 | - |
dc.identifier.citation | Family Office Networks. 2022. Family Offices Boost Investments in Seed Rounds for Emerging Companies to Fuel Growth.https://familyofficenetworks.com/family-offices-boost-investments-in-seed-rounds-for-emerging-companies-to-fuel-growth/. Accessed June 27, 2024.
FasterCapital. 2024. What is a Micro VC Fund. https://fastercapital.com/content/What-is-a-Micro-VC-Fund.html. Accessed June 27, 2024. Glaveckaitė, Z. 2020. Early stage startup development: the critical success factors’ perspective. Doctoral dissertation, Mykolas Romeris University, Vilnius, Lithuanian. Gormley, B. 2023. Venture Interest in Medical Devices Holds Up, but Investors Are Choosy. https://www.wsj.com/articles/venture-interest-in-medical-devices-holds-up-but-investors-are-choosy-11673659713. Accessed June 15, 2024. Hyun, S. 2022. Positive Effect of Portfolio Financing Strategy for Startups. Economic Analysis and Policy, 74, 623-626. Igoe, S. 2022. This is How Medical Device Startups are Raising Money in 2021. https://jauntup.com/resources/this-is-how-medical-device-startups-are-raising-money-in-2021/. Accessed May 18, 2024. Lerner, J. 1994. The syndication of venture capital investments. Financial Management, 23(3), 16-27. Loizos, C. 2017. Cendana Capital — which funds 15 top seed-stage groups — just raised a ton of capital. https://techcrunch.com/2017/04/05/cendana-capital-which-funds-15-top-seed-stage-groups-just-raised-a-ton-of-capital/. Accessed June 17, 2024. Loten, A. 2023. Startups are hitting a funding wall after seed stage. https://www.wsj.com/articles/startups-are-hitting-a-funding-wall-after-seed-stage-16b81af6. Accessed June 4, 2024. Krieglstein, T. 2013. Tranche Investing Will Kill Your Startup--Here's Why. https://www.forbes.com/sites/entrepreneursorganization/2013/12/20/tranche-investing-will-kill-your-startup-heres-why/. Accessed June17, 2024. Matejka, F. 2016. Venture Debt Financing for Start-up Companies. Master’s Thesis, Tilburg University, Tilburg, Netherlands. MEDICAL BUYER. 2023. MedTech industry contributes 16% to US GDP. https://www.medicalbuyer.co.in/medtech-industry-contributes-16-to-us-gdp/. Accessed May 10, 2024. Metzke, R. 2023. Innovating for patients and planet: driving equitable and sustainable healthcare. https://www.philips.com/a-w/about/news/archive/blogs/innovation-matters/2023/20230914-innovating-for-patients-and-planet-driving-equitable-and-sustainable-healthcare.html. Accessed May 23, 2024. Niftyhontas, I. 2024. Exploring the Surge of Micro VCs: The New Frontier of Startup Investment. https://www.goingvc.com/post/exploring-the-surge-of-micro-vcs-the-new-frontier-of-startup-investment. Accessed June 3, 2024. Pattison, K. 2009. The new rules of angel investing. https://www.nytimes.com/2009/10/29/business/smallbusiness/29angels.html. Accessed May 30, 2024. Rowley, D. J. 2018. Inside The Global Q2 2018 Venture Market: New Records And Titanic Late-Stage Rounds. https://news.crunchbase.com/venture/inside-the-global-q2-2018-venture-market-new-records-and-titanic-late-stage-rounds/. Accessed June 2, 2024. Slauko, B. 2020. What Alberta’s early-stage funding gap means for founders. https://metiquity.ca/about/research/seed-series-part-3/. Accessed May 24, 2024. Snyder, G., Gupta, L., Varia, H. 2022. New strategies for medtech startups. https://www2.deloitte.com/content/dam/Deloitte/us/Documents/life-sciences-health-care/new-strategies-for-medtech-startups.pdf. Accessed May 30, 2024. Thompson, M. 2021. The Shifting Start-Up Ecosystem: Insights on the Future of Medtech. https://www.mystrategist.com/medtech-strategist/article/the_shifting_start-up_ecosystem_insights_on_the_future_of_medtech_.html. Accessed June 15, 2024. Vrionis, J. 2018. Venture Capital Is Losing Sight Of Its Most Important Investments: Seed-Stage Entrepreneurs. https://www.forbes.com/sites/valleyvoices/2018/11/16/mega-funds-create-seed-gap/#18632d8a7892. Accessed May 20, 2024. Wagner, P. 2020. Seed is the New A – But What’s Next. https://www.wing.vc/content/seed-is-the-new-a-but-whats-next. Accessed May 10. | - |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/93938 | - |
dc.description.abstract | 傳統創投(VC)公司由於基金規模的增加,正逐漸將焦點從早期投資轉向後期投資,這要求企業達成顯著的里程碑才能引起興趣。這一趨勢在醫療科技領域尤其顯著,因為該領域面臨將創新推向市場的獨特挑戰,資金缺口也特別大。天使投資人、微型創投(Micro VC)和家族辦公室等早期投資者試圖填補這一缺口,但遭遇嚴重的稀釋風險,這導致一個惡性循環,阻礙了早期投資,並使醫療科技初創企業籌集資金變得更加困難。本文探討了一種新的聯合投資策略,旨在減少這些稀釋風險並打破這個惡性循環,研究方法包括產業關鍵意見領袖(KOL)的見解和一個由三位早期投資者參與的試點計劃。
本研究顯示,如果該聯合投資策略能夠成功實施,對企業家和早期投資者都將有顯著的好處。然而,該策略需要大量的協調和溝通,以確保聯合投資成員在分期投資結構上達成一致。所以如果成員間具彼此信任條件並且擁有相似願景、基金壽命和目標回報的話,這將有助於提高執行此策略的成功機率。此外,要實現該策略需要的資金配置的話,聯合投資成員可能至少需要四名,使得此類聯合投資的形成具有一定的機遇性。與策略性投資者合作減少所需成員的數量,可能會提高形成此類聯合投資的成功機會。 | zh_TW |
dc.description.abstract | Traditional venture capital (VC) firms are shifting focus from early-stage deals to later-stage investments due to increasing fund sizes, requiring ventures to achieve significant milestones before attracting interest. This trend is especially impactful in the medtech sector, which faces substantial funding gaps due to the unique challenges of bringing innovations to market. Early Investors, such as angels, micro VCs, and family offices, attempt to bridge this gap but encounter severe dilution risks, creating a vicious cycle that deters early-stage investment and complicates capital raising for medtech startups. This paper explores a new investment syndication strategy designed to mitigate these dilution risks and break the cycle, assessed through industry KOL insights and a pilot program with three Early Investors.
The study indicates significant advantages for both entrepreneurs and Early Investors if the syndication strategy is successfully implemented. However, the strategy requires substantial coordination and communication to align syndication members, especially regarding tranche structuring. Initiating syndication with members sharing similar visions, fund lifespans, and target returns, and fostering strong trust, could increase success chances. Adequate capital allocation likely requires at least four members, making syndication formation opportunistic. Partnering with strategics to reduce member numbers could improve the chances of successfully forming such a syndication. | en |
dc.description.provenance | Submitted by admin ntu (admin@lib.ntu.edu.tw) on 2024-08-09T16:33:01Z No. of bitstreams: 0 | en |
dc.description.provenance | Made available in DSpace on 2024-08-09T16:33:02Z (GMT). No. of bitstreams: 0 | en |
dc.description.tableofcontents | Contents
口試委員會審定書 I Acknowledgements II 中文摘要 III THESIS ABSTRACT IV Contents V Figure of Contents VII Table of Contents VIII Chapter 1 Introduction 1 1-1 Background 1 1-2 Motives of the Study 4 1-3 Purpose and Outline of the Study 4 Chapter 2 Review of Literature 5 2-1 Access to Finance is Key to Startups 5 2-2 Challenges in Early-Stage Financing 6 2-3 Venture Debt 7 2-4 Equity Financing 8 2-5 Startup Funding Landscape is Going Through a Major Transformation 9 Chapter 3 Ecosystem of Medtech Startup Investing 11 3-1 Development Stages of Medtech Startups 11 3-2 Investing in Early Medtech Startups Comes with Unique Challenges 14 3-3 Dilution Risks of Investors Investing in Early Stage Medtech Startups 18 3-4 Existing Strategies that Protect Early Investors Against Dilution 20 Chapter 4 Methodology 24 4-1 Methods of Verifying the Feasibility of the Proposed Syndication Strategy 24 4-2 The Survey 24 4-3 The Pilot Program 27 4-4 About Firm F 28 Chapter 5 Presentation of Research 29 5-1 Survey Results 29 5-2 Observations and Lesson Took from the Pilot Program 33 5-3 Discussion 35 Chapter 6 Conclusions 40 References 41 Figure of Contents Figure 1-1:Medtech Covers Devices, Healthcare IT, IVD / Imaging 2 Figure 2-1:Critical success factors of a startup at an early stage 5 Figure 2-2:Series A investors demand revenue generation 9 Figure 2-3:Funding Gap Widens as VC fund size increases 10 Figure 3-1:Investment / Development Stages of Medtech Ventures 11 Figure 3-2:Sources of Funding in Early Stage Medtech Startups 12 Figure 3-3:the Interplay amongst Healthcare Stakeholders 16 Figure 3-4:Typical Medtech Startup Valuation Growth Trajectory in Real Life 18 Figure 3-5:the Victious Cycle Faced by Early Medtech Investors 19 Figure 3-6:A New Strategy that Mitigates Dilution Risks 23 Figure 4-1:Two Ways to Evaluate Feasibility of the Proposed Strategy 24 Table of Contents Table 4-1:Key Opinion Leader Profile Snapshots 27 Table 5-1:Tally Results regarding to Opportunities & Challenges 36 | - |
dc.language.iso | en | - |
dc.title | 降低投資者投資在早期醫療科技新創的被稀釋風險:一種積極型聯合投資策略研究 | zh_TW |
dc.title | Mitigating Dilution Risks for Investors Investing in Early Stage Medtech Startups – an Active Syndication Strategy | en |
dc.type | Thesis | - |
dc.date.schoolyear | 112-2 | - |
dc.description.degree | 碩士 | - |
dc.contributor.coadvisor | 尤琳蕙 | zh_TW |
dc.contributor.coadvisor | Lin-Hui Yu | en |
dc.contributor.oralexamcommittee | 黃祥宇;俞明德;陳聖賢 | zh_TW |
dc.contributor.oralexamcommittee | Siang-Yu Huang;Min-Teh Yu;Sheng-Syan Chen | en |
dc.subject.keyword | 醫療科技,微型創投,稀釋風險,聯合投資,分期投資,價值拐點, | zh_TW |
dc.subject.keyword | Medtech,Micro VC,Dilution risks,Syndication,Investment tranches,Value inflection point, | en |
dc.relation.page | 43 | - |
dc.identifier.doi | 10.6342/NTU202402099 | - |
dc.rights.note | 未授權 | - |
dc.date.accepted | 2024-07-31 | - |
dc.contributor.author-college | 管理學院 | - |
dc.contributor.author-dept | 碩士在職專班會計與管理決策組 | - |
顯示於系所單位: | 會計與管理決策組 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-112-2.pdf 目前未授權公開取用 | 2.88 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。